N. Renkvist

发表

Identification of a Mutated Receptor-Like Protein Tyrosine Phosphatase κ as a Novel, Class II HLA-Restricted Melanoma Antigen1

P. Robbins, G. Parmiani, C. Castelli, 2003, The Journal of Immunology.

T‐cell recognition of melanoma‐associated antigens

G. Parmiani, C. Castelli, L. Rivoltini, 2000 .

The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.

G. Schuler, T. Boon, K. Thielemans, 2009, Cancer research.

The CD 4 + T-Cell Response of Melanoma Patients to a MAGE-A 3 Peptide Vaccine Involves Potential Regulatory T Cells

P. Bruggen, G. Schuler, T. Boon, 2009 .

A polyclonal anti‐vaccine CD4 T cell response detected with HLA‐DP4 multimers in a melanoma patient vaccinated with MAGE‐3.DP4‐peptide‐pulsed dendritic cells

N. Glaichenhaus, G. Schuler, T. Boon, 2005, European journal of immunology.

Vaccination of a Melanoma Patient with Mature Dendritic Cells Pulsed with MAGE-3 Peptides Triggers the Activity of Nonvaccine Anti-Tumor Cells1

B. Neyns, F. Brasseur, T. Boon, 2008, The Journal of Immunology.

Monitoring of Anti-Vaccine CD4 T Cell Frequencies in Melanoma Patients Vaccinated with a MAGE-3 Protein1

A. Eggermont, T. Boon, K. Thielemans, 2005, The Journal of Immunology.

Anti-Tumor Cells Peptides Triggers the Activity of Nonvaccine Mature Dendritic Cells Pulsed with MAGE-3 Vaccination of a Melanoma Patient with Boon and Danièle Godelaine

B. Neyns, F. Brasseur, P. Bruggen, 2008 .

Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues.

G. Parmiani, M. Maeurer, C. Castelli, 2003, Cancer research.

Optimized Analogues Altered Peptide Ligands : Role of MelanA / MART-1 T Cells by Melanoma-derived + Suboptimal Activation of CD 8 Updated Version

G. Parmiani, M. Maeurer, C. Castelli, 2003 .

T-cell recognition of melanoma-associated antigens.

G. Parmiani, C. Castelli, L. Rivoltini, 2000, Journal of cellular physiology.

A listing of human tumor antigens recognized by T cells

P. Robbins, G. Parmiani, C. Castelli, 2001, Cancer Immunology, Immunotherapy.

Functional characterisation of the T cell mediated anti tumour response in a melanoma patient : identification of a HLA DRβ1*10011 restricted unique antigen.

N. Renkvist, 2002 .